INSIGHTS ON DRUG DEVELOPMENT

• Is Industry Ready To Take A Bite Out Of Obesity?

  What are the clinical, economic, and policy considerations for a class of drugs offering a promising treatment for obesity, and how is the industry adapting to meet demand?

• MAPK Signaling Pathway

  Mitogen-activated protein kinase cascades regulate key cellular processes like proliferation, differentiation, and apoptosis. Explore how these pathways maintain cellular homeostasis and contribute to disease development.

• AI-Enabled Phenotypic Analysis Of Label-Free Intestinal Organoids

  Discover how advanced 3D models and AI-enabled imaging techniques revolutionize organoid research, which provides accurate phenotypic analysis to monitor growth and development in various organoid types.

• Bioanalytical Quantification Of A Biotherapeutic Peptide

  Discover a sensitive, selective, and robust LC-MS method for quantifying semaglutide in plasma with advanced sample preparation and detection technologies for accurate results in bioanalytical research.

• Five Practical Considerations To Move From Concept To Clinic

  12/17/2025

  Learn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.

• White Paper: Nasal Delivery Of Spray Dried Biologics: Opportunities And Challenges

  10/16/2024

  Explore the potential of spray-dried nasal formulations for biologics to achieve excellent stability and targeted delivery, paving the way for innovative and effective therapeutic solutions.

• Nanomedicine Modalities Find Path To Clinic Through Analytics

  5/16/2025

  Lipid nanoparticles have revolutionized drug delivery, ushering in a new era of nanomedicine. Discover how advanced analytical tools are accelerating next-generation LNP therapeutics.

• Duodenum Intestine-Chip For Modeling Human Physiology

  3/14/2024

  Discover an Intestine-Chip that integrates the robust cell sourcing of organoids with Organs-on-Chips technology to overcome experimental limitations and yield a closer-to-human transcriptomic profile.

• Improving In Vitro Cancer Modeling

  8/2/2024

  Organ-on-a-Chip technology represents a significant advancement in drug discovery. By mimicking human physiology, Organ-Chips can enhance the predictive accuracy of preclinical models and accelerate drug development.